关注
Valentina Petito
Valentina Petito
Fondazione Policlinico Universitario Agostino Gemelli IRCSS- Università Cattolica del Sacro Cuore
在 unicatt.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Commensal Clostridia: leading players in the maintenance of gut homeostasis
LR Lopetuso, F Scaldaferri, V Petito, A Gasbarrini
Gut pathogens 5, 1-8, 2013
8482013
Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease
FR Ponziani, S Bhoori, C Castelli, L Putignani, L Rivoltini, F Del Chierico, ...
Hepatology 69 (1), 107-120, 2019
5382019
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility
F Scaldaferri, V Gerardi, LR Lopetuso, F Del Zompo, F Mangiola, ...
BioMed research international 2013 (1), 435268, 2013
2992013
Nutrition and IBD: malnutrition and/or sarcopenia? A practical guide
F Scaldaferri, M Pizzoferrato, LR Lopetuso, T Musca, F Ingravalle, ...
Gastroenterology research and practice 2017 (1), 8646495, 2017
1922017
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update
F Scaldaferri, V Gerardi, F Mangiola, LR Lopetuso, M Pizzoferrato, ...
World journal of gastroenterology 22 (24), 5505, 2016
1922016
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders.
IG Macchione, LR Lopetuso, G Ianiro, M Napoli, G Gibiino, G Rizzatti, ...
European Review for Medical & Pharmacological Sciences 23 (18), 2019
1782019
Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: time for microbial marker of gastrointestinal disorders
LR Lopetuso, V Petito, C Graziani, E Schiavoni, F Paroni Sterbini, ...
Digestive diseases 36 (1), 56-65, 2017
1742017
The role of antibiotics in gut microbiota modulation: the eubiotic effects of rifaximin
FR Ponziani, F Scaldaferri, V Petito, F Paroni Sterbini, S Pecere, ...
Digestive Diseases 34 (3), 269-278, 2016
1532016
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors
LR Lopetuso, F Scaldaferri, G Bruno, V Petito, F Franceschi, A Gasbarrini
European review for medical and pharmacological sciences 9 (6), 1068-1076, 2015
1472015
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
LR Lopetuso, C De Salvo, L Pastorelli, N Rana, HN Senkfor, V Petito, ...
Proceedings of the National Academy of Sciences 115 (40), E9362-E9370, 2018
992018
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities.
C Graziani, A GASBARRINI, F SCALDAFERRI, C TALOCCO, R SIRE, ...
European Review for Medical & Pharmacological Sciences 23 (2), 2019
942019
The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease
G Holleran, L Lopetuso, V Petito, C Graziani, G Ianiro, D McNamara, ...
International journal of molecular sciences 18 (10), 2020, 2017
882017
Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases.
R De Sire, G Rizzatti, F Ingravalle, M Pizzoferrato, V Petito, L Lopetuso, ...
Minerva gastroenterologica e dietologica 64 (4), 351-362, 2018
832018
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol‐associated liver disease
G Addolorato, FR Ponziani, T Dionisi, C Mosoni, GA Vassallo, L Sestito, ...
Liver International 40 (4), 878-888, 2020
802020
Influence of hepatitis C virus eradication with direct‐acting antivirals on the gut microbiota in patients with cirrhosis
FR Ponziani, L Putignani, F Paroni Sterbini, V Petito, A Picca, ...
Alimentary Pharmacology & Therapeutics 48 (11-12), 1301-1311, 2018
802018
Gut–joint axis: The role of physical exercise on gut microbiota modulation in older people with osteoarthritis
A De Sire, R de Sire, V Petito, L Masi, C Cisari, A Gasbarrini, F Scaldaferri, ...
Nutrients 12 (2), 574, 2020
792020
Inflammatory bowel diseases and sarcopenia: the role of inflammation and gut microbiota in the development of muscle failure
OM Nardone, R de Sire, V Petito, A Testa, G Villani, F Scaldaferri, ...
Frontiers in Immunology 12, 694217, 2021
782021
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease
A Ancona, C Petito, I Iavarone, V Petito, L Galasso, A Leonetti, L Turchini, ...
Digestive and Liver Disease 53 (3), 298-305, 2021
672021
Characterization of the gut‐liver‐muscle axis in cirrhotic patients with sarcopenia
FR Ponziani, A Picca, E Marzetti, R Calvani, G Conta, F Del Chierico, ...
Liver International 41 (6), 1320-1334, 2021
622021
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center
M Pizzoferrato, R de Sire, F Ingravalle, MC Mentella, V Petito, AM Martone, ...
Nutrients 11 (10), 2281, 2019
592019
系统目前无法执行此操作,请稍后再试。
文章 1–20